1. Home
  2. CTRM vs BNGO Comparison

CTRM vs BNGO Comparison

Compare CTRM & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castor Maritime Inc.

CTRM

Castor Maritime Inc.

HOLD

Current Price

$2.17

Market Cap

21.1M

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.53

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRM
BNGO
Founded
2016
2003
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
21.1M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CTRM
BNGO
Price
$2.17
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
54.3K
208.9K
Earning Date
12-03-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$75,412,579.00
$28,720,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$1.41
52 Week High
$2.92
$6.98

Technical Indicators

Market Signals
Indicator
CTRM
BNGO
Relative Strength Index (RSI) 54.45 45.23
Support Level $2.02 $1.41
Resistance Level $2.20 $1.75
Average True Range (ATR) 0.10 0.09
MACD 0.00 0.00
Stochastic Oscillator 91.30 32.35

Price Performance

Historical Comparison
CTRM
BNGO

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: